Cereno Scientific's CS1 Treatment Shows Promising Safety Profile in PAH Patients Over a Year Cereno Scientific announces positive safety results for its CS1 treatment in PAH patients after a 12-month study, supporting its development as an oral therapy.

Cereno Scientific's CS1 Treatment Shows Promising Safety Profile in PAH Patients Over a Year #Sweden #Gothenburg #Cereno_Scientific #CS1_Treatment #PAH_Patients